Literature DB >> 17526570

R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts.

Huamei He1, Maryam M Javadpour, Farhana Latif, Jil C Tardiff, Joanne S Ingwall.   

Abstract

It is now known that the flexibility of the troponin T (TnT) tail determines thin filament conformation and hence cross-bridge cycling properties, expanding the classic structural role of TnT to a dynamic role regulating sarcomere function. Here, using transgenic mice bearing R-92W and R-92L missense mutations in cardiac TnT known to alter the flexibility of the TnT tropomyosin-binding domain, we found mutation-specific differences in the cost of contraction at the whole heart level. Compared to age- and gender-matched sibling hearts, mutant hearts demonstrate greater ATP utilization measured using (31)P NMR spectroscopy as decreases in [ATP] and [PCr] and |DeltaG(~ATP)| at all workloads and profound systolic and diastolic dysfunction at all energetic states. R-92W hearts showed more severe energetic abnormalities and greater contractile dysfunction than R-92L hearts. The cost of increasing contraction was abnormally high when [Ca(2+)] was used to increase work in mutant hearts but was normalized with supply of the beta-adrenergic agonist dobutamine. These results show that R-92L and R-92W mutations in the TM-binding domain of cardiac TnT alter thin filament structure and flexibility sufficiently to cause severe defects in both whole heart energetics and contractile performance, and that the magnitude of these changes is mutation specific.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526570      PMCID: PMC1948064          DOI: 10.1529/biophysj.107.107557

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  21 in total

1.  Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

Authors:  T Palm; S Graboski; S E Hitchcock-DeGregori; N J Greenfield
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity.

Authors:  Larry S Tobacman; Mahta Nihli; Carol Butters; Mark Heller; Victoria Hatch; Roger Craig; William Lehman; Earl Homsher
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

3.  A modulatory role for the troponin T tail domain in thin filament regulation.

Authors:  Robin Maytum; Michael A Geeves; Sherwin S Lehrer
Journal:  J Biol Chem       Date:  2002-06-03       Impact factor: 5.157

4.  Regulatory proteins alter nucleotide binding to acto-myosin of sliding filaments in motility assays.

Authors:  E Homsher; M Nili; I Y Chen; L S Tobacman
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

5.  Microassay of free and total creatine from tissue extracts by combination of chromatographic and fluorometric methods.

Authors:  H Kammermeier
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

6.  Shifts in the myosin heavy chain isozymes in the mouse heart result in increased energy efficiency.

Authors:  Kirsten Hoyer; Maike Krenz; Jeffrey Robbins; Joanne S Ingwall
Journal:  J Mol Cell Cardiol       Date:  2006-10-19       Impact factor: 5.000

7.  Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart.

Authors:  K W Saupe; M Spindler; J C Hopkins; W Shen; J S Ingwall
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

8.  Cardiac dysfunction in hypertrophic cardiomyopathy mutant tropomyosin mice is transgene-dependent, hypertrophy-independent, and improved by beta-blockade.

Authors:  Daniel E Michele; Carlen A Gomez; Katie E Hong; Margaret V Westfall; Joseph M Metzger
Journal:  Circ Res       Date:  2002-08-09       Impact factor: 17.367

9.  Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.

Authors:  Maryam M Javadpour; Jil C Tardiff; Ilka Pinz; Joanne S Ingwall
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  34 in total

Review 1.  Mechanical and energetic consequences of HCM-causing mutations.

Authors:  Cecilia Ferrantini; Alexandra Belus; Nicoletta Piroddi; Beatrice Scellini; Chiara Tesi; Corrado Poggesi
Journal:  J Cardiovasc Transl Res       Date:  2009-10-09       Impact factor: 4.132

2.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

Review 3.  Proteasome dysfunction in cardiomyopathies.

Authors:  Jennifer E Gilda; Aldrin V Gomes
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

4.  Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor γ-independent mitochondrial oxidative stress in mouse hearts.

Authors:  Huamei He; Hai Tao; Hui Xiong; Sheng Zhong Duan; Francis X McGowan; Richard M Mortensen; James A Balschi
Journal:  Toxicol Sci       Date:  2014-01-21       Impact factor: 4.849

Review 5.  Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.

Authors:  Andrea E Deranek; Matthew M Klass; Jil C Tardiff
Journal:  Pflugers Arch       Date:  2019-03-08       Impact factor: 3.657

6.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

7.  Atomic resolution probe for allostery in the regulatory thin filament.

Authors:  Michael R Williams; Sarah J Lehman; Jil C Tardiff; Steven D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

8.  Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific.

Authors:  Huamei He; Kirsten Hoyer; Hai Tao; Ronald Rice; Jesus Jimenez; Jil C Tardiff; Joanne S Ingwall
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

9.  Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.

Authors:  Raffaella Lombardi; Achim Bell; Vinitha Senthil; Jasvinder Sidhu; Michela Noseda; Robert Roberts; Ali J Marian
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

10.  It's never too early to look: subclinical disease in sarcomeric dilated cardiomyopathy.

Authors:  Jil C Tardiff
Journal:  Circ Cardiovasc Genet       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.